YOLFTbeta
Dabomb Protein

Dabomb Protein

6578 · TWO · Consumer Defensive / Packaged Foods

16.60TWD-0.10 (-0.60%)

Price History

Full chart

Market Stats

Previous Close16.70
Open16.85
Day Range16.60 – 16.85
52-Week Range14.35 – 22.30
Volume34.20K
Market Cap1.18B
P/E (TTM)0.00
Forward P/E0.00
EPS-0.58
Dividend Yield0.00%
Beta0.35
50-Day Avg17.50
200-Day Avg17.66

About

DaBomb Protein Biotech Corp. manufactures and sells hydrolyzed soy protein in Vietnam, the Philippines, South Korea, Taiwan, and Asia. It offers nutrition and health care for aquatic products and economic animals; and pet health care products. The company also offers contract development and manufacturing organization services, including research and development, process design, and mass production services; product packaging solutions; and product formulation design and customized development services. It serves pet health food brands, pet nutrition product distribution channels, livestock feed enterprises, animal nutrition brands, and aquaculture industries. The company was formerly known as DaBomb Protein Corp. and changed its name to DaBomb Protein Biotech Corp. in October 2023. DaBomb Protein Biotech Corp. was incorporated in 2001 and is based in Tainan City, Taiwan.

Company Details

  • SectorConsumer Defensive
  • IndustryPackaged Foods
  • CEOWei Chen Chen
  • Employees0
  • HeadquartersNo. 52, Industrial 3rd Rd, Tainan City, Taiwan, 709, Taiwan
  • Websitehttps://www.dabombprotein.com

Leadership

  • Wei Chen ChenGM & Chairperson
  • Yahui YaoAccounting Supervisor
  • Jing Xing LiuDeputy General Manager of Marketing Department

Financials

Income Statement

Currency: TWD2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue804.59M726.76M562.38M622.85M646.60M605.22M470.63M433.63M384.41M337.82M309.33M
Growth (%)--9.67%-22.62%+10.75%+3.81%-6.40%-22.24%-7.86%-11.35%-12.12%-8.43%
Cost of Revenue639.99M559.58M441.14M505.55M516.87M505.95M448.98M414.30M337.99M269.10M240.30M
Gross Profit164.59M167.18M121.25M117.30M129.73M99.27M21.65M19.33M46.43M68.73M69.03M
Gross Margin20.46%23.00%21.56%18.83%20.06%16.40%4.60%4.46%12.08%20.34%22.32%
Operating Expense78.21M83.72M80.19M86.06M90.60M85.05M88.69M61.81M94.14M70.55M97.22M
Operating Income86.38M83.46M41.05M31.24M39.13M14.22M-67.04M-42.48M-47.72M-1.82M-28.18M
Operating Margin10.74%11.48%7.30%5.02%6.05%2.35%-14.24%-9.80%-12.41%-0.54%-9.11%
EBITDA--52.00M46.89M49.91M39.83M-40.80M-15.49M-26.00M34.98M-22.25M
EBITDA Margin--9.25%7.53%7.72%6.58%-8.67%-3.57%-6.76%10.35%-7.19%
Net Income62.19M68.31M28.02M25.14M21.19M7.19M-62.45M-44.66M-57.02M11.64M-69.34M
Net Income Margin7.73%9.40%4.98%4.04%3.28%1.19%-13.27%-10.30%-14.83%3.44%-22.42%
R&D7.30M5.11M5.18M5.97M11.29M14.15M11.82M11.85M13.59M14.95M16.23M
R&D as % of Total Revenue0.91%0.70%0.92%0.96%1.75%2.34%2.51%2.73%3.54%4.42%5.25%
Interest Expense0001.92M1.30M2.59M4.58M6.58M8.23M5.21M3.07M
Interest Expense % of Total Revenue0.00%0.00%0.00%0.31%0.20%0.43%0.97%1.52%2.14%1.54%0.99%

Balance Sheet

Currency: TWD2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets729.95M819.88M851.06M841.91M919.35M1.06B1.34B1.28B1.40B1.32B1.10B
Total Liabilities137.31M200.11M228.29M131.39M220.96M356.66M662.24M552.88M443.83M225.96M106.48M
Total Equity592.64M619.77M622.77M710.52M698.39M700.51M674.24M727.20M958.06M1.09B989.28M
Cash461.18M436.69M380.17M199.75M206.36M265.61M197.13M195.18M379.99M253.59M132.16M
Total Debt-----292.53M618.30M496.04M418.00M--
Net Debt-----26.93M421.17M300.87M38.02M--

Cash Flow

Currency: TWD2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow139.78M59.58M43.87M22.07M33.26M13.41M-44.25M19.71M6.51M47.55M16.65M
Investing Cash Flow-17.51M-87.17M-167.81M-160.29M-90.24M-63.49M-382.75M12.96M---
Financing Cash Flow-66.47M14.23M73.39M-41.16M62.56M112.43M356.71M-34.15M208.85M--
Capital Expenditure5.33M92.71M166.46M163.06M91.81M18.31M332.09M20.16M18.87M30.32M37.69M
Free Cash Flow---122.59M-140.99M-58.55M-4.90M-376.35M-449.00K-12.37M17.23M-21.04M
Dividends Paid8.91M27.80M21.89M12.84M23.40M14.68M6.03M---12.23M
FCF to OCF---279.47%-638.75%-176.04%-36.53%850.44%-2.28%-190.10%36.24%-126.41%
Dividend Paid to FCF---17.86%-9.10%-39.96%-299.67%-1.60%----58.12%

Key Statistics & Ratios

Market Cap1.18B
Enterprise Value1.11B
Trailing P/E0.00
Forward P/E0.00
Price / Sales3.49
Price / Book1.20
EPS-0.58
Book Value14.03
Revenue (TTM)339.44M
Gross Profit (TTM)80.80M
EBITDA23.48M
Profit Margin-12.35%
Operating Margin9.36%
Return on Equity-4.11%
Return on Assets-1.14%
Shares Outstanding71.94M
Shares Float33.22M
Beta0.35
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio565.85%

Dividends

20251×
0.40Jul 8, 2025
20241×
0.51Jul 30, 2024
20231×
0.67Jul 27, 2023
20211×
0.20Aug 23, 2021
20201×
0.45Jul 2, 2020
20191×
0.71Aug 27, 2019
20181×
0.45Jul 19, 2018
20171×
0.76Aug 21, 2017
20161×
0.97Aug 25, 2016

Stock Splits

  • Aug 23, 20211100:1000
  • Aug 21, 20171050:1000
  • Aug 25, 20161050:1000